Operator
Operator
Good morning, ladies and gentlemen. At this time, we would like to welcome everyone to Ultrapar's Fourth Quarter 2018 Results Conference Call. There is also a simultaneous webcast that may be accessed through Ultrapar's website at ri.ultra.com.br and on the MZiQ platform. Please feel free to flip through the slides during the conference call. Today, with us, we have Mr. André Pires, Chief Financial and Investor Relations Officer, together with other executives of Ultrapar. We would like to inform you that this event is being recorded. [Operator Instructions]. A replay of this call will be available for 1 week. Before proceeding, let me mention that forward-looking statements are being made under the safe harbor of the Securities Litigation Reform Act of 1996. Forward-looking statements are based on the beliefs and assumptions of Ultrapar management and on information currently available to the company. They involve risks, uncertainties and assumptions because they relate to future events and therefore, depend on circumstances that may or may not occur in the future. Investors should understand that general economic conditions, industry conditions and other operating factors could also affect the future results of Ultrapar and could cause results to differ materially from those expressed in such forward-looking statements. Now I'll turn the conference over to Mr. Pires. Mr. Pires, you may begin the conference. André Pires: Thank you very much. Hello, everyone. It's a pleasure to be here with you to discuss Ultrapar's fourth quarter 2018 results, and also to tell you about our perspectives and priorities for the next quarters. With me today are the officers from our businesses as well as our Investor Relations team. Starting with Slide 3. Let's begin with the consolidated results for Ultrapar in the fourth quarter. Net revenues amounted to BRL23 billion, 10% higher than in the fourth quarter of 2017, with growth in all our businesses. Adjusted EBITDA was BRL993 million, a reduction of 5% compared with the same quarter in 2017 due to lower EBITDA at Ipiranga and Extrafarma. However, in relation to the third quarter of 2018, we saw a 17% increase in adjusted EBITDA. During the fourth quarter, we continue to see a gradual recovery in Ipiranga, both in terms of margins and market share, following a period of a more challenging operating environment during the first half of 2018 and more intense competition. Net earnings were BRL496 million, an increase of 27% compared with the fourth quarter of 2017, mainly due to better financial results despite the lower EBITDA in the period. In 2018, Ultrapar's net revenues were BRL91 billion, 14% higher than in 2017, again reflecting the increase in revenues at all the businesses. Adjusted EBITDA reached BRL3.1 billion, a decrease of 23% in relation to the previous year due to lower EBITDA at Ipiranga, Extrafarma and Ultragaz. The latter being impacted by the break-up fee from CADE's rejection of the Liquigás acquisition in February. Net earnings for 2018 were BRL1.1 billion, a 26% reduction compared to 2017. The Board of Directors approved a distribution of BRL380 million in dividends for the second half of the year, equivalent to BRL0.70 per share, which, together with the dividends paid in August, corresponds to a payout ratio of 60% for 2018 and a dividend yield of 2.5%. Ultrapar net debt was BRL8.2 billion in December 2018, a reduction of BRL1 billion compared to September. That's equivalent to a leverage of 2.7x net debt to EBITDA and lower than the 2.9x for the third quarter of 2018. Reduction in financial leverage was due to an important increase in operating cash flow generation in the quarter coming from initiatives to optimize working capital and more steady activity in our CapEx plan. 2018 CapEx was BRL1.9 billion, a 15% decrease compared with 2017 and 27% less than our original budget announced in December of 2017. For 2019, we announced CapEx plan of BRL1.8 billion, which is lower than 2018, but sufficient to keep the company sustainable growth. We are committed to the selectivity and discipline of capital allocation, and we have undertaken a series of initiatives with our partners which will allow us to grow with lower CapEx. Thanks to these initiatives, we ended 2018 with operating cash flow generation of BRL1.4 billion, an increase of BRL1.1 billion compared to 2017, despite a BRL912 million reduction in EBITDA for the period. Let's now move on to Ipiranga's performance in Slide 4. Sales volume in the fourth quarter of 2018 reached 6.2 million cubic meters, an increase of 4% compared with the fourth quarter of 2017, with growth of 5% in Otto cycle and 3% in diesel, with an improvement in sales especially to the reseller segment. In the Otto cycle, such growth came after three consecutive quarters of decline, an important sign of recovery. Now I'd like to draw your attention to the new criteria adopted for the number of service stations disclosed. The aim is to provide greater consistency between the published network figure and the volumes sold. The principle difference is that now we are reporting network additions from the inauguration of service stations, where in the previous model, the criteria was from the signing of the contract. You can find more information on this thing in our earnings release on our table on Page 17. The am/pm continued store chain grew by a further 78 stores, 67 bakeries and 54 beer caves compared with same period in 2017. The Abastece Ai reached the 5 million transactions mark in the fourth quarter of 2018, with the inclusion of more than 1.4 million new clients driven by the year-end holiday commercial campaigns. The results for the quarter showed the positive progression from the third quarter of 2018 and continued the trend observed in the last few months. Adjusted EBITDA fell by 35% from the fourth quarter of 2017 due to lower margins given the strong comparative days with import gains in the fourth quarter of 2017 as well as the negative impact of inventory in the fourth quarter of 2018. Looking at the full year performance. Sales volumes reached 23.7 million cubic meters, a growth of 1% over 2017. This breaks down into an expansion of 2% in diesel and a decrease of 1% in the Otto cycle. Adjusted EBITDA was BRL2.1 billion, 33% lower when compared to 2017 due to a higher comparative days, which imports -- with imports and inventory gains in 2017 and also due to the impact of the truckers drivers' strike in 2018. We have noticed a more balanced approach in an environment of the beginning of this year as a result of the recent reduction in fuel costs, which contributed to faster demand growth and a pricing policy in line with international parity. For 2019, we expect growth above the GDP growth in volume as well as a significant recovery in EBITDA relative to 2018. Volumes so far have outperformed our forecast for diesel, and we saw a greater mix of ethanol in the case of the Otto cycle. With this, we expect to see growth in volume compared with the first quarter of 2018, and we continue to observe a sequential improvement in profitability adjusted by the seasonality among periods. And now moving on to Slide 5, talking about Oxiteno. Oxiteno's total sales volume in the fourth quarter of 2018 was 190,000 tons, a reduction of 6% compared to the fourth quarter of 2017. Specialty chemical sales volume fell by 10% again in relation to the same quarter in 2017 due to lower sales to the other business and automotive segments and to Argentina, despite higher sales in United States. Commodity volumes increased by 12% over the same period in 2017. This due to the stronger demand from the domestic market. Oxiteno's EBITDA was BRL280 million in the quarter, of which BRL186 million is the net effect of tax credits from a final ruling in Oxiteno's favor on the exclusion of the ICMS tax -- sales tax from the PIS/COFINS calculation base. If we exclude this effect, EBITDA would have reached BRL94 million, a 22% increase compared to the fourth quarter of 2017 due to an improvement in margins and depreciation in exchange rates during the period. Looking at the performance for the full year. Total sales volume at Oxiteno was 769,000 tons, a reduction of 3% compared with 2017. This was due to a 5% lower sales of specialty comments, despite an increase of 8% in commodities. Without considering nonrecurring tax credits, Oxiteno's EBITDA for 2018 was BRL439 million, an increase of 48% compared to 2017 due to both a higher unitary margins in U.S. dollars and a more depreciated real. The new Texas unit is ramping up operations according to plan. Production is increasing, and there have been some important commercial developments with the signing of new contracts and the certification of products for new markets and segments. For 2019, we expect to see a continuation in Oxiteno's favorable operational environment driven by the gradual ramp up in the new plant and contributing to increase volume and profitability. For the current quarter, we are forecasting an increase in sales volume as well as EBITDA relative to the first quarter of 2018. Moving on to Slide 6 and talking about the performance of Ultragaz. In the fourth quarter, sales volume was down by 1% on a year-on-year basis. The bottled segment grew by 1%, while bulk volumes declined by 5% mainly due to weaker demand in the industrial segment. EBITDA at Ultragaz was BRL121 million in the quarter, an increase of 151% compared with the fourth quarter of 2017 and a reduction of 8% if we exclude the amount of the agreement signed with the antitrust authority in the fourth quarter of 2017, again, largely due to lower sales volume to the industrial segment. In 2018, sales volume fell by 1% in relation to 2017, in line with the decline in the overall Brazilian LPG market. The bulk segment fell by 3% and the bottled segment remained stable. In this scenario, Ultragaz market share was unchanged in relation to 2017. If we exclude the nonrecurring impacts, EBITDA for 2018 was BRL544 million, a 4% improvement in relation to 2017 mainly due to the reduction in SG&A expense. For 2019, we expect to see volume grow in line with GDP, with greater upside in the bulk segment and an increased EBITDA as a result of gains in operational efficiency. For the current quarter, we are forecasting similar volumes and EBITDA close to those of the first quarter of 2018, excluding the break-up fee from the rejection of the Liquigas acquisition. Moving on now to Slide 7, talking about Ultracargo, where Ultracargo's average storage increased by 1% compared with the fourth quarter of 2017. This was due to greater ethanol-handling activities at the Aratu, Santos and Suape terminals, more than offsetting the reduction in fuels handling businesses. In the quarter, Ultracargo's EBITDA was BRL40 million, 8% higher than the same period in 2017, influenced by greater average storage and price adjustments at the terminals. For the full year, average storage rose by 5% due to the partial resumption of operations at Santos terminal. EBITDA amounted to BRL178 million, an increase of 44% over 2017 due to greater storage capacity combined with tariff adjustments. Additionally, 2017 results were still impacted by some residual expenses relating to the 2015 incident. For the current year, we continue to observe a positive market dynamic, maintaining the growth trends in result reported in 2018. In addition, we expect an increase in average storage capacity, following expansion at the Santos and Itaqui terminals. Let's move on now to Slide 8, talking about Extrafarma. Extrafarma entered the fourth quarter of 2018 with 433 drugstores, a gross addition of 68 in the last 12 months and 27 new stores in the fourth quarter. At the end of the period, 55% of the stores have been opened for less than 3 years, the same level as the fourth quarter of 2017. Extrafarma's gross revenues in the fourth quarter of '18 increased by 1% in relation to the fourth quarter of '17, representing a 5% growth in retail sales. This reflects the result of a larger average number of stores and the annual adjustment pharmaceutical prices, offset by the residual impacts from the installation of the new retail system and a competitive environment under more pressure. EBITDA for the quarter was negative BRL15 million, impacted by the large number of new stores, fewer of them at the maturing stage and the residual effects of the newer systems and more intense competition. In 2018, gross revenues reached BRL2.1 billion, 8% above 2017 due to greater number of stores. EBITDA, in turn, was a negative BRL47 million due to the high percentage of new stores still at the maturing stage, the impact from the stabilization of the new retail system and a more accelerated process of store closures during the year. In 2019, we expect to reduce our rate of expansion in view of the continued challenging business environment. The outlook is for increased gross revenues due to the maturation process in the store network. Those reverse in [indiscernible] results recorded in 2018. For the current quarter, we are expecting a growth in revenues, with EBITDA still influenced by the peaking store rollouts in the fourth quarter of 2018, and by a competitive business scenario, which remains under pressure. Moving on now to Slide 9. To conclude, I would like to comment on some of the initiatives we have been taking in 2018 as well as highlighting our priorities and perspectives for 2019. With an EBITDA of BRL3.1 billion and net earnings of BRL1.1 billion, Ultrapar delivered solid results in 2018, although below our expectations. Over the year, we advanced our planned succession process at our businesses, renewing the leadership at Ipiranga, Extrafarma and Ultragaz. We also strengthened some other senior management positions with the appointment of talent selected from both inside and outside of the company to add skills and experience to our team. We took important measures during 2018 such as being more selective in our CapEx, focusing on improving the effectiveness in the capital efficient process and optimizing our working capital. As a result, Ultrapar was able to generate an operating cash flow of BRL1.4 billion in spite of a reduced EBITDA, confirming the company's financial solvence. We are optimistic as to the prospective for improvements in the Brazilian economy, with growth in GDP and greater generation of income and employment. These are factors which contribute directly to the performance of our businesses. Ultrapar never stops investing in a significant and consistent manner over the past few years, even during the recent recession in Brazil, and this will allow us to pursue a growth trajectory in a solid and sustainable way. In 2019, we continue committed to operational excellence at our businesses, adopting steps to reduce costs and expenses and for the optimization of working capital. We shall maintain discipline in the allocation of capital, at the same time, focusing on our cash generation. We expect to reduce our financial leverage in the coming quarters. This will increase our capacity to invest and to look after organic and inorganic opportunities. Our outlook at Ultrapar is for an improved results at our businesses. Consequently, we expect to see a significant increase in Ultrapar's EBITDA in 2019 compared to 2018, mainly due to the evolution in Ipiranga's results and the recovery in the Extrafarma business. We are convinced that we are taking the necessary measures to create value for our shareholders and all our stakeholders. With this, I would like to finish my presentation for today. Thanks for your attention. We can now start the Q&A session.